A century later, that sentiment is as pertinent as ever. Artificial Intelligence (AI) is being incorporated into a myriad of ...

OmniaBio, a subsidiary of Canada's Centre for Commercialization of Regenerative Medicine, has opened a 120,000-square-foot ...

Shanghai-based biopharma LaNova Medicines has raised 3 billion yuan ($41 million) in a series C round led by China ...

Taiwan-based REGiMMUNE, a biopharma creating immunotherapies through the power of regulatory T cells (Tregs), and ...